- Home
- AVTX vs NREF Comparison
AVTX vs NREF Comparison
Compare AVTX & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- NREF
- Stock Information
- Founded
- AVTX 2011
- NREF 2019
- Country
- AVTX United States
- NREF United States
- Employees
- AVTX N/A
- NREF N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- NREF Real Estate Investment Trusts
- Sector
- AVTX Health Care
- NREF Real Estate
- Exchange
- AVTX Nasdaq
- NREF Nasdaq
- Market Cap
- AVTX 248.3M
- NREF 250.2M
- IPO Year
- AVTX 2015
- NREF 2020
- Fundamental
- Price
- AVTX $17.99
- NREF $13.68
- Analyst Decision
- AVTX Strong Buy
- NREF Hold
- Analyst Count
- AVTX 9
- NREF 3
- Target Price
- AVTX $30.14
- NREF $14.75
- AVG Volume (30 Days)
- AVTX 417.9K
- NREF 47.0K
- Earning Date
- AVTX 11-07-2025
- NREF 10-30-2025
- Dividend Yield
- AVTX N/A
- NREF 14.62%
- EPS Growth
- AVTX N/A
- NREF N/A
- EPS
- AVTX N/A
- NREF 2.59
- Revenue
- AVTX $441,000.00
- NREF $121,573,000.00
- Revenue This Year
- AVTX N/A
- NREF $27.27
- Revenue Next Year
- AVTX N/A
- NREF $5.40
- P/E Ratio
- AVTX N/A
- NREF $5.28
- Revenue Growth
- AVTX N/A
- NREF 302.49
- 52 Week Low
- AVTX $3.39
- NREF $12.14
- 52 Week High
- AVTX $19.41
- NREF $18.09
- Technical
- Relative Strength Index (RSI)
- AVTX 69.56
- NREF 46.50
- Support Level
- AVTX $15.58
- NREF $13.37
- Resistance Level
- AVTX $19.20
- NREF $13.69
- Average True Range (ATR)
- AVTX 1.66
- NREF 0.31
- MACD
- AVTX 0.26
- NREF 0.03
- Stochastic Oscillator
- AVTX 77.22
- NREF 61.44
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.